The invention here relates to a product comprised of a cell line or lines intended for use as an allogeneic immunotherapy agent for the treatment of cancer in mammals and humans. All of the studies of cell-based cancer vaccines to date have one feature in common, namely the intention to ...
Traditional cancer treatments that are focused on eliminating cancer cells, like radiation therapy and chemotherapy, can have debilitating physical and emotional side effects and often have limited success with metastatic cancers. These types of treatments also do not often result in a long-term cure,...
However, treatments for certain cancers have seen more progress than others. Patients with cancers such as testicular cancer,melanoma,prostate cancer,Hodgkin’s lymphoma,breast cancerand uterine cancer are surviving much longer than before. However, treatments forliver cancerandpancreatic ca...
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma. They also identified potenti...
findings through vivo models. They found that delivering antigen-presenting neutrophils or simply modulating the leucine diet dramatically boosted the antitumor immune response in mice, and the treatments also markedly improved outcomes of PD-1 checkpoint immunotherapy across a range of cancer types. ...
and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma. They also identified potential targeted treatments based on the findings, as reported inScience Advancesin November...
the tumor of a cancer patient. The technology identifies the “driver mutations” which are involved in the cancer’s progression. The technology can also screen a series of cancer drugs to determine which treatments are likely to be most effective at shutting down these particular driver ...
Center4cancer - new cancer treatments Cancer, which surpassed heart disease as the number one killer in America in 2005, is still considered 'a mystery' in conventional medicine. In fact, the term 'cancer' is just a generic term that in no way describes its cause. ...
The invention here relates to a product comprised of a cell line or lines intended for use as an allogeneic immunotherapy agent for the treatment of cancer in mammals and humans. All of the studies of cell-based cancer vaccines to date have one feature in common, namely the intention to use...
in 1997. He graduated from Duke University Medical School in 2002 as a member of the Alpha Omega Alpha medical honor society. While in medical school, he participated in a year-long laboratory research program at the University of California at San Francisco investigating new cancer treatments. ...